Facilitated By

San Antonio Medical Foundation

Mapping Drug Resistance Genes in Plasmodium falciparum

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Anderson, Timothy J. C.
Collaborating Institutions
University of Notre Dame
Columbia University
Funded by
NIH-PMS
Research Start Date
Status
Active

Artemisinin combination therapy (ACT) is the main treatment for Plasmodium falciparum malaria: the success of this treatment has rolled back malaria and renewed interest in malaria elimination. Slow clearance of parasites following ACT treatment of patients in SE Asia has lead to concern about the spread of resistance. This proposal aims to identify the genes that underlie slow clearance to better understand the evolution and biochemical basis of his trait.

Collaborative Project
Genetics
Infectious Disease